WT1 and neoplasm: Additionally, HMA application after transplantation can reactivate tumor suppressor genes and re-expression HLA-DR in tumor cells (26), and is associated with an increase in the proportion of WT1 positive cytotoxic T lymphocytes (WT1+CTL) (27).